Skip to content
DomDNA LAB

Research library · Health literacy

Your eGFR result needs the test method beside the number

DomDNA editorial resources · Released · Research 2026-10-04 · 4 min read

Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.

An eGFR result often arrives as a number with a flag beside it. That compact display leaves out an important detail: the “e” means estimated. Before comparing it with an older result or a friend's screenshot, it helps to know what went into the estimate and why the test was ordered.

This does not make the result disposable. An estimate can be clinically useful while still needing context. The question to bring to an appointment is how the result fits the rest of your assessment, rather than whether one number proves your kidneys are healthy or unhealthy.

What the estimate uses

Many eGFR calculations use blood creatinine. NIDDK's explanation of clinical measurements describes factors beyond kidney filtration that can affect creatinine, including muscle mass and diet. Rapidly changing kidney function also creates difficulties for estimation. A plausible explanation for a result is not, by itself, proof that the result can be ignored.

Cystatin C is another marker used in estimation. It has limitations too. NIDDK's equation guidance explains that combining creatinine and cystatin C can improve accuracy, particularly when a result sits near a clinical decision threshold. That is a reason for a clinical discussion, not an instruction to buy every available kidney test.

The equation and marker belong in the record when available. If a report does not name them, leave that detail as unknown and ask whether it matters for the comparison you are making. Guessing the method from the number's appearance adds an avoidable assumption.

Read the report as a record

Save the whole report, including the collection date, units, laboratory comments and any accompanying results. A cropped image containing only the flagged number may be convenient to share, but it can make a later explanation harder. Keep an unedited copy somewhere you can find it before the appointment.

If you are preparing a timeline, distinguish sample collection from the date you opened the message. Write down why each test happened if you know. “Routine review” and “tested during an acute illness” are different pieces of context; neither is a conclusion about the result.

Bring a current medicines and supplements list. Describe recent circumstances without deciding which one caused the change. You do not need to write a defence of your exercise routine or produce a theory before asking for help. A short, accurate account gives the clinician something usable to work with.

The urine result may answer another question

The NHS explanation of kidney-disease diagnosis describes both blood testing and urine testing, including the albumin-to-creatinine ratio. It also explains that further or repeat testing may be needed. An eGFR screenshot alone does not contain that wider assessment.

Ask whether a urine result is part of your review and what, if anything, remains outstanding. This is especially useful when results arrive as separate messages. A simple list headed “received”, “awaiting explanation” and “next step agreed” can prevent a missing result from looking like a reassuring result.

Avoid assigning yourself a diagnosis from an online threshold table. Equally, do not dismiss an abnormal result because you have found a possible non-kidney explanation. The clinical team can judge which explanations deserve investigation and how urgently to act.

Leave with a follow-up you understand

A productive final question is: “What happens next, and who will contact me?” If another sample is planned, note the timing and any preparation instructions. If no repeat is needed, ask what made the current information sufficient. Record the answer in ordinary language you can understand later.

There is no need to turn every health measurement into a daily project. The useful outcome is a clear interpretation and an agreed plan, with enough detail preserved to make the next conversation easier. For general lifestyle education based on your answers, explore DomDNA's free educational health quiz. It does not calculate kidney function, interpret laboratory results or replace clinical care.

Original source and access ledger

  1. NIDDK measurement context

    sourceDate: Reviewed 2025-05

    type: Government clinical measurement guidance

    population: Patients whose kidney function is estimated from filtration markers

    endpoint: Non-GFR determinants and estimation accuracy

    supportedClaimAndLimit: Creatinine has muscle/diet influences; unstable kidney function complicates estimates. These do not justify dismissing a result.

    fundingAndConflicts: NIH institute guidance; not a commercial assay comparison.

    accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.

    researchDate: 2026-10-04

    correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.

  2. NIDDK filtration equations

    sourceDate: Date not established; accessed 2026-10-04

    type: Government equation guidance

    population: Clinical eGFR assessment; equation suitability depends on population

    endpoint: Estimated filtration accuracy

    supportedClaimAndLimit: Combined creatinine/cystatin C can improve accuracy near decision thresholds; no universal testing prescription.

    fundingAndConflicts: NIH institute; article does not validate an equation in an individual.

    accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.

    researchDate: 2026-10-04

    correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.

  3. NHS kidney assessment

    sourceDate: Date not established; accessed 2026-10-04

    type: Public clinical guidance

    population: People assessed for chronic kidney disease in UK care

    endpoint: Diagnostic assessment and follow-up

    supportedClaimAndLimit: Blood and urine tests, including ACR, contribute; repeat testing may be needed. One screenshot is not a full diagnosis.

    fundingAndConflicts: NHS public information; no commercial test referral.

    accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.

    researchDate: 2026-10-04

    correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.

Download exact original article Markdown · Download exact source and unsent social pack

Finished companion media

Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.